| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 22 |
| 1 | RITUXIMAB | 16 |
| 2 | TACROLIMUS | 16 |
| 3 | PREDNISOLONE | 14 |
| 4 | PREDNISOLONE ORAL | 14 |
| 5 | PREDNISOLONE ORAL SOLUTION | 14 |
| 6 | DOXORUBICIN | 13 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 |
| 8 | TACROLIMUS OINTMENT 0.1% | 13 |
| 9 | MYCOPHENOLATE MOFETIL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 3 | 0.0089 |
| 1 | FLOXURIDINE | 1 | 0.0058 |
| 2 | PRAZIQUANTEL | 1 | 0.0033 |
| 3 | ETHIODIZED OIL | 3 | 0.0023 |
| 4 | MEBENDAZOLE | 1 | 0.0013 |
| 5 | MITOMYCIN | 4 | 0.0011 |
| 6 | GLUTATHIONE | 1 | 0.0006 |
| 7 | ALBENDAZOLE | 1 | 0.0005 |
| 8 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0005 |
| 9 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 4 | 0.0049 |
| 1 | Anthelmintic [EPC] | 2 | 0.0007 |
| 2 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 5 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 22 | 0.0001 |
| 8 | Radiographic Contrast Agent [EPC] | 3 | 0.0001 |
| 9 | Anti-anginal [EPC] | 1 | 0.0001 |